Pepdox
Studies
Peptides
Calculator
Editorial: Incretin agonists in the treatment of obesity. | Pepdox
Home
/
Search
/
PMID 37621651
Editorial: Incretin agonists in the treatment of obesity.
Frontiers in endocrinology
2023
PMID: 37621651
View on PubMed
DOI: 10.3389/fendo.2023.1265826
Semaglutide
Authors
Sun, Xiaodong; Hu, Miaofen G; Li, Lixin
Keywords
Dual GIP/GLP-1R agonists
GIP
GLP-1
GLP-1R agonists
incretins
liraglutide
obesity
semaglutide